Samil Pharmaceutical Co., Ltd. operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Samil Pharmaceutical Co., Ltd. with three other
companies in this sector in KOREA (SOUTH) :
Hwail Pharmaceutical Company Limited
sales of 108.74 billion Korean Won [US$92.76 million]
Ctc Bio, Incorporation.
(136.12 billion Korean Won [US$116.11 million]
of which 80%
was Animal Medication), and
(115.18 billion Korean Won [US$98.25 million]
of which 24%
was Health Functional Food).
Samil Pharmaceutical Co., Ltd. reported sales of 121.11 billion Korean Won (US$103.30 million)
December of 2019.
increase of 28.0%
versus 2018, when the company's sales were 94.60 billion Korean Won .